ALKERMES | ALKS - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.48B 110M 2026-03
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
ALKERMES USD 456.48M 48.85M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 23.48B 2.3B 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
J&J USD 22.54B 1.21B 2026-03
Malin Corporation EUR 500K 300K 2024-12
Merck USD 12.21B 435M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Otsuka Holdings JPY 595.39B 58.02B 2026-06
Ovoca Bio EUR 53K 14K 2025-12
Pfizer USD 16.19B 19M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06